Trial Profile
Efficacy of Alpha-Blocker Add-on Therapy to Tadarafil Treated Men with Lower Urinary Tract Sympton
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2019
Price :
$35
*
At a glance
- Drugs Naftopidil (Primary) ; Silodosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- 05 Apr 2019 Status changed from recruiting to discontinued.
- 09 Oct 2014 New trial record